Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SEMG1/2 augment energy metabolism of tumor cells. | Cell Death Dis | 2020 | 33311447 | PubTator, text mining | PubMed |
| Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab. | J Immunother Cancer | 2020 | 33298619 | PubTator, text mining | PubMed |
| Role of immunotherapy in Ewing sarcoma. | J Immunother Cancer | 2020 | 33293354 | PubTator, text mining | PubMed |
| Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? | Int J Mol Sci | 2020 | 33291277 | PubTator, text mining | PubMed |
| Gene Augmentation and Editing to Improve TCR Engineered T Cell Therapy against Solid Tumors. | Vaccines (Basel) | 2020 | 33287413 | PubTator, text mining | PubMed |
| Adoptive T cell therapy: Boosting the immune system to fight cancer. | Semin Immunol | 2020 | 33262066 | PubTator, text mining | PubMed |
| Immune Regulation by Dendritic Cell Extracellular Vesicles in Cancer Immunotherapy and Vaccines. | Cancers (Basel) | 2020 | 33260499 | PubTator, text mining | PubMed |
| Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer. | Cancers (Basel) | 2020 | 33256070 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Drug Delivery Systems in Cancer. | Pharmaceutics | 2020 | 33256036 | PubTator, text mining | PubMed |
| Autologous non-human primate model for safety assessment of piggyBac transposon-mediated chimeric antigen receptor T cells on granulocyte-macrophage colony-stimulating factor receptor. | Clin Transl Immunology | 2020 | 33251009 | PubTator, text mining | PubMed |
| Precise T cell recognition programs designed by transcriptionally linking multiple receptors. | Science | 2020 | 33243890 | PubTator, text mining | PubMed |
| Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells. | Front Oncol | 2020 | 33240813 | PubTator, text mining | PubMed |
| Inflammation and immunity in ovarian cancer. | EJC Suppl | 2020 | 33240443 | PubTator, text mining | PubMed |
| Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers. | Cancers (Basel) | 2020 | 33233705 | PubTator, text mining | PubMed |
| Dexosomes as a cell-free vaccine for cancer immunotherapy. | J Exp Clin Cancer Res | 2020 | 33228747 | PubTator, text mining | PubMed |
| Clinical implication of cellular vaccine in glioma: current advances and future prospects. | J Exp Clin Cancer Res | 2020 | 33228738 | PubTator, text mining | PubMed |
| MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. | PLoS One | 2020 | 33227008 | PubTator, text mining | PubMed |
| Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy. | Mol Ther Oncolytics | 2020 | 33209979 | PubTator, text mining | PubMed |
| Effect of 5-aza-2'-deoxycytidine on Estrogen Receptor Alpha/Beta and DNA Methyltransferase 1 Genes Expression, Apoptosis Induction, and Cell Growth Prevention of the Colon Cancer HT 29 Cell Line. | Int J Prev Med | 2020 | 33209217 | PubTator, text mining | PubMed |
| Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials. | Int J Mol Sci | 2020 | 33207653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=52